Treatment Registry
TR-0621 ActiveRecorded September 2026

Unspecified GLP-1

Sold by ElleS · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$179

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Starting price · recorded initial monthly payment$179

Added from the figures recorded below.

Price

TermPer monthCharged today
Starting price

“Get started for only $ 179 Clinician-reviewed care, personalized to your goals, without long-term commitments or hidden fees. What's included? FREE consultation Custom Dosing GLP-1 Medication FREE Delivery Transparent pricing”

Per month$179Charged today$179
Price sources
Visit ElleS

We earn nothing from this link. It opens ElleS's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberBoth

Not yet checked: pharmacy, states, cancellation, membership and consult fee.

Recorded from ellesvi.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The company is ElleS Care LLC per the footer. The site never names semaglutide or tirzepatide anywhere in the crawled text — treatment is described only as 'GLP-1 Medication' — so drug is recorded as unspecified GLP-1. $179 is explicitly listed as including the medication itself ('GLP-1 Medication' is one of the line items under 'What's included?'), so it is recorded as a price, not a membership fee. The /category/weight-loss product listing page and the /legal/terms-of-service page are both client-rendered with essentially no server-side text (283 and 2,254 chars respectively, almost all nav/footer boilerplate), so no product-level drug breakdown, states list, or explicit cancellation/refund policy could be read; the terms page links out to an external Freshdesk article (support.careglp.com) that 404'd.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0621
Medication category
unspecified GLP-1
Readings
1

Related records

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 73 records of the same molecule.

Cite this entry

Treatment Registry. (2026). ElleS — unspecified GLP-1 (TR-0621). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0621

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.